Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CeraVe vs Half Mu for Skin Barrier Repair
NCT04185025Unknown
- Sponsor
- Peking University First Hospital
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial in xerosis cutis (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Self-assessment from patients at 17 days. Status: unknown.
02
Conditions
xerosis cutis
Beyond the preview
Go deeper on NCT04185025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04185025.